Resultats de la cerca - M. Piutti
- Mostrar 1 - 2 resultats de 2
-
1
Pathological response and safety of two neoadjuvant strategies with bevacizumab in MRI-defined locally advanced T3 resectable rectal cancer: a randomized, noncomparative phase II s... per Christophe Borg, Thierry André, G. Mantion, F. Boudghène, F. Mornex, P. Maingon, Antoine Adenis, D. Azria, M. Piutti, O. Morsli, Jean-François Bosset
Publicat 2014Artigo -
2
Prospective analysis of the impact of <i>VEGF‐A</i> gene polymorphisms on the pharmacodynamics of bevacizumab‐based therapy in metastatic breast cancer patients per Marie‐Christine Etienne‐Grimaldi, Patricia Formento, Armelle Degeorges, Jean‐Yves Pierga, R. Delva, Xavier Pivot, Florence Dalenc, Marc Espié, Corinne Veyret, Jean‐Louis Formento, M Francoual, M. Piutti, Patricia de Crémoux, G. Milano
Publicat 2010Artigo
Eines de cerca:
Matèries relacionades
Bevacizumab
Cancer
Chemotherapy
Internal medicine
Medicine
Breast cancer
Chemoradiotherapy
Clinical endpoint
Colorectal cancer
Environmental health
FOLFOX
Metastatic breast cancer
Oncology
Oxaliplatin
Pharmacodynamics
Pharmacokinetics
Phases of clinical research
Population
Prospective cohort study
Randomized controlled trial
Surgery
Taxane
Total mesorectal excision